Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial

Solomon, Scott; Rizkala, Adel; Lefkowitz, Martin; Shi, Victor; Gong, JianJian; Anavekar, Nagesh; Anker, Stefan; Arango, Juan; Arenas, Jose; Atar, Dan; Ben-Gal, Turia; Boytsov, Sergey; Chen, Chen-Huan; Chopra, Vijay; Cleland, John; Comin-Colet, Josep; Duengen, Hans-Dirk; Echeverria Correa, Luis; Filippatos, Gerasimos; Flammer, Andreas; Galinier, Michel; Godoy, Armando; Goncalvesova, Eva; Janssens, Stefan; Katova, Tzvetana; Kober, Lars; Lelonek, Malgorzata; Linssen, Gerard; Lund, Lars; O'Meara, Eileen; Merkely, Bela; Milicic, Davor; Oh, Byung-Hee; Perrone, Sergio; Ranjith, Naresh; Saito, Yoshihiko; Saraiva, Jose; Shah, Sanjiv; Seferovic, Petar; Senni, Michele; Sibulo, Antonio; Sim, David; Sweitzer, Nancy; Taurio, Jyrki; Vinereanu, Dragos; Vrtovec, Bojan; Widimsky, Jiri; YILMAZ, MEHMET; Zhou, Jingmin; Zweiker, Robert; Anand, Inder; Ge, Junbo; Lam, Carolyn; Maggioni, Aldo; Martinez, Felipe; Packer, Milton; Pfeffer, Marc; Pieske, Burkert; Redfield, Margaret; Rouleau, Jean; Van Veldhuisen, Dirk; Zannad, Faiez; Zile, Michael; McMurray, John

doi:10.1161/circheartfailure.118.004962

Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial

Solomon S. D., Rizkala A. R., Lefkowitz M. P., Shi V. C., Gong J., Anavekar N., ...Daha Fazla

CIRCULATION-HEART FAILURE, cilt.11, sa.7, 2018 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 11 Sayı: 7
Basım Tarihi: 2018
Doi Numarası: 10.1161/circheartfailure.118.004962
Dergi Adı: CIRCULATION-HEART FAILURE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: angiotensin receptor antagonists, endopeptidases, heart failure, diastolic, clinical trial
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

BACKGROUND: To describe the baseline characteristics of patients with heart failure and preserved left ventricular ejection fraction enrolled in the PARAGON-HF trial (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin Receptor Blocker Global Outcomes in HFpEF) comparing sacubitril/valsartan to valsartan in reducing morbidity and mortality.